NYSEConsumer StaplesBeverages - AlcoholicSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflow5 key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Beer Business net sales grow to at least $2.43 billion | Constellation Brands grows its Beer Business sales from $2.22B to $2.43B in one quarter. | Under Pressure | Beer Business net sales fall below $2.22 billion | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Beer Business net sales grew from approximately $2.23B in 2026-Q1 to $2.47B in 2027-Q2, with shipment volumes increasing similarly. The segment consistently leads the U.S. beer category in dollar and volume share gains. Management's statements align with the financial data, indicating delivery on growth and share gains. Delivery assessment Oct 15, 2026 |
Operating income in Beer Business rises to at least $845 million | Profit in Beer rose from $442M to $845M. | Under Pressure | Operating income falls below $442 million | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Beer Business net sales grew from approximately $2.23B in 2026-Q1 to $2.47B in 2027-Q2, with shipment volumes increasing similarly. The segment consistently leads the U.S. beer category in dollar and volume share gains. Management's statements align with the financial data, indicating delivery on growth and share gains. Delivery assessment Oct 15, 2026 |
Capital expenditures near $800 million to support brewery expansions | A supporting condition in Constellation Brands's published investment case. The stated target is ~$800 million. | Intact | Capital expenditures fall significantly below $800 million | Capital expenditures: $177.2M FY2027-Q2; GAAP. Published target: ~$800 million. The stored target says 2027-Q1; this source reports FY2027-Q2. Fiscal/calendar alignment needs review. Source published Oct 7, 2026177,200,000 USD · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2027-Q2 · Period ending Aug 31, 2026 Source: stock_quarterly_financials_fmp. Reference: 2027-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 6 quarters. Management continues to invest in modular brewery expansions in Mexico, including progressing the third brewery at Veracruz. Capital expenditures of approximately $3 billion are planned from fiscal 2025 to 2028. The trajectory shows ongoing investment consistent with stated priorities. Delivery assessment Oct 15, 2026 |
Quarterly dividend maintained at $1.03 per share | The company keeps paying a steady dividend of $1.03 per share quarterly. | Intact | Dividend falls below $1.02 per share | Required source inputs unavailable Cannot calculate Dividend per share from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Management has consistently declared a quarterly cash dividend of $1.03 per share from 2026-Q1 through 2027-Q2. The dividend amount has been stable, indicating delivery on this capital allocation commitment. Delivery assessment Oct 15, 2026 |
Free cash flow reaches at least $1.6 billion | Free cash flow is guided near $1.65B for fiscal 2027. | Under Pressure | Free cash flow falls below $1.3 billion | Free cash flow: $-839M FY2027-Q2; GAAP. Published target: >= $1.6 billion. The stored target says 2027-Q1; this source reports FY2027-Q2. Fiscal/calendar alignment needs review. Source published Oct 7, 2026-839,000,000 USD · calculatedSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2027-Q2 · Period ending Aug 31, 2026 Source: stock_quarterly_financials_fmp. Reference: 2027-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Management consistently emphasizes a disciplined and balanced capital allocation approach, returning over $800 million to shareholders through share repurchases and dividends year-to-date 2027-Q2, while maintaining a target comparable net leverage ratio of ~3.0x. The trajectory is delivering with ongoing execution of capital allocation priorities and shareholder returns. Delivery assessment Oct 15, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsLatest: 14 Buy / Strong Buy · 9 Hold · 2 Sell / Strong Sell
Recent actions · Sep 16–Oct 15 · 17 recorded
0 raises · 6 cuts · 0 unchanged · 6 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings5 of 5 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a durable compounder with a focus on steady growth in the beer segment and a strategic shift in its wine and spirits portfolio. The current thesis state is intact, supported by recent strong financial performance.
The market seems to have priced in a justified valuation with a slight expectations gap, indicating that investors may not fully anticipate the potential for continued growth in STZ's core businesses. There is low fragility in the current setup, suggesting stability in the face of market fluctuations.
Management's disciplined capital allocation and focus on growth in the beer business are likely to support fundamentals in the near term. However, there is a moderate risk due to potential economic headwinds and the possibility of guidance cuts.
The long-term thesis hinges on management's ability to maintain growth momentum in the beer segment and successfully execute on their strategic focus in wine and spirits. Additionally, external factors such as inflation trends and economic conditions will play a crucial role in shaping future performance.
Overall, STZ appears well-positioned for the next 1 to 3 years, but it must navigate moderate risks and sector challenges. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.